Mikael C.O. Englund

1.1k citations
15 papers · 890 indexed · h-index 13
Topics
Pluripotent Stem Cells Research (6 papers)CRISPR and Genetic Engineering (5 papers)Cholesterol and Lipid Metabolism (4 papers)

In The Last Decade

Mikael C.O. Englund

15 papers receiving 866 citations

Peers

Mikael C.O. Englund
Comparison fields: 5 of 80
  • Molecular Biology 581
  • Surgery 351
  • Immunology 157
  • Genetics 112
  • Endocrinology, Diabetes and Metabolism 77
Replace Rachel Lotan with:
Rachel Lotan Israel
Dian Wang China
A.S. Daoud United States
Katti Fischer-Dzoga United States
Elizabeth Rendina-Ruedy United States
Inger Hagen Norway
Jian Kang China
Jennifer Kench United States
J.-B. Michel France
Mikael C.O. Englund relative to Rachel Lotan Israel Rachel Lotan's profile →
Citations per field
00.5×1.5×2.4×
Rachel Lotan · 1×
Citations per year

Countries citing papers authored by Mikael C.O. Englund

Since Specialization
Citations

This map shows the geographic impact of Mikael C.O. Englund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikael C.O. Englund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikael C.O. Englund more than expected).

Fields of papers citing papers by Mikael C.O. Englund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikael C.O. Englund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikael C.O. Englund. The network helps show where Mikael C.O. Englund may publish in the future.

Co-authorship network of co-authors of Mikael C.O. Englund

This figure shows the co-authorship network connecting the top 25 collaborators of Mikael C.O. Englund. A scholar is included among the top collaborators of Mikael C.O. Englund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikael C.O. Englund. Mikael C.O. Englund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 2
2 8
3 17
4 18
5 55
6 31
7 46
8 21
9 21
10 181
11 222
12 49
13 29
14 38
15 152

About Mikael C.O. Englund

Mikael C.O. Englund is a scholar working on Biochemistry, Immunology and Molecular Biology, having authored 15 papers that have together received 890 indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (6 papers), CRISPR and Genetic Engineering (5 papers) and Cholesterol and Lipid Metabolism (4 papers). The work is most often cited by research in Biochemistry (51 citations), Molecular Biology (581 citations) and Surgery (351 citations). Mikael C.O. Englund has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Olov Wiklund, Bertil G. Ohlsson, Henrik Semb, Anders Lindahl, Ulf Dahl, Charles Hanson, Nico Heins, Christina Bergh, Cecilia Sjöblom and Erik Knutsen. Their work appears in journals such as Journal of Clinical Investigation, Diabetes and Stem Cells.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026